To cite this paper use one of the standards below:
The intracellular phenylalanine/tyrosine (Phe/Tyr) ratio is a metabolic marker of impaired phenylalanine hydroxylase activity and disrupted cellular metabolism under tetrahydrobiopterin (BH4) deficiency. We investigated whether redox-active metal coordination compounds containing 1-[bis(pyridine-2-ylmethyl)amino]-3-chloropropan-2-ol (HP) ligand, such as Cu, Fe, Mn and ZnHP, could modulate this metabolic imbalance in C6 glioma cells treated with the BH4 synthesis inhibitor SPRi3. This inhibitor increased neopterin levels, reduced tyrosine, promoted phenylalanine accumulation, and elevated the Phe/Tyr ratio. Among the compounds tested, CuHP and FeHP significantly lowered the Phe/Tyr ratio, indicating improved metabolic balance. CuHP also markedly reduced neopterin accumulation, while FeHP resulted in undetectable neopterin levels, suggesting a distinct mechanism of action. In contrast, MnHP and ZnHP decreased neopterin but failed to improve the Phe/Tyr ratio. These findings indicates that CuHP and FeHP effectively modulate cellular metabolism under conditions of impaired Phe/Tyr homeostasis.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper